N-methylhistamine, Urine

Sample type: Urine

Other names: N METHYLHISTAMINE, RANDOM, U

Optimal result: 30 – 200 mcg/g Creat.

Elevated levels of N-methylhistamine in urine are typically associated with conditions involving increased mast cell activity. This can include disorders such as mastocytosis or mast cell activation syndrome. Additionally, high levels may be observed in various allergic reactions, gastrointestinal food allergies, irritable bowel disease, chronic urticaria (hives), angioedema, and interstitial cystitis. In these cases, the increased N-methylhistamine levels reflect heightened histamine release from mast cells, which can contribute to the symptoms experienced in these conditions.

Low levels of N-methylhistamine in urine have been linked to several conditions. These include depression, lupus, focal segmental glomerulosclerosis, and idiopathic nephrotic syndrome. Additionally, alterations in the histamine N-methyltransferase gene can also result in low levels of N-methylhistamine. This metabolite is a significant byproduct of histamine metabolism and is typically evaluated in the context of assessing mast cell activity. Therefore, low levels might indicate altered histamine metabolism or reduced mast cell activity in these specific conditions.

N-methylhistamine in urine is a significant biomarker with growing interest in the medical community, particularly in the diagnosis and monitoring of mast cell activation disorders. This compound, a metabolite of histamine, provides crucial insights into the activity of mast cells within the body. Mast cells, known for their role in allergic responses, release histamine among other mediators during activation. Elevated levels of N-methylhistamine in urine can indicate increased mast cell activity, which is a characteristic feature of conditions like mastocytosis or mast cell activation syndrome (MCAS).

N-methylhistamine in urine is a significant biomarker with growing interest in the medical community, particularly in the diagnosis and monitoring of mast cell activation disorders. This compound, a metabolite of histamine, provides crucial insights into the activity of mast cells within the body. Mast cells, known for their role in allergic responses, release histamine among other mediators during activation. Elevated levels of N-methylhistamine in urine can indicate increased mast cell activity, which is a characteristic feature of conditions like mastocytosis or mast cell activation syndrome (MCAS).

The measurement of urinary N-methylhistamine is especially relevant in cases where other clinical symptoms are ambiguous or when there is a need to confirm a suspected diagnosis of a mast cell disorder. This testing becomes a vital tool in the comprehensive evaluation of patients presenting with symptoms like flushing, hives, abdominal pain, diarrhea, and anaphylaxis, which are often associated with mast cell activation.

Furthermore, urinary N-methylhistamine testing holds value in monitoring the efficacy of treatments in patients with known mast cell disorders. Adjustments in therapy, whether they involve antihistamines, mast cell stabilizers, or other targeted treatments, can be guided by changes in the levels of this biomarker.

In the broader context of allergy and immunology research, the study of N-methylhistamine and its implications in mast cell-related diseases is an expanding field. It offers potential for better understanding of these conditions and paves the way for the development of more effective diagnostic and therapeutic strategies.

N-methylhistamine, Urine
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond N-methylhistamine, Urine — 10,000+ markers explained
One N-methylhistamine, Urine result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro